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Tuberculosis (TB) is caused by Mycobacterium tuberculosis. Although TB is a curable disease, it continues to 
be one of the most important infectious causes of death worldwide. Indonesia ranks 3rd  on the list of TB high 
burden countries in the world with 86,000 cases deaths and the Multi Drug Resistant Tuberculosis (MDR TB) 
estimated cases in Indonesia is 10,000. This research was aimed to isolate and characterize of soft coral 
Sinularia sp.-associated bacteria having antibacterial activity against Tuberculosis bacteria.   There were 
109 isolates collected from Sinularia sp. Two isolates from Sinularia sp.-associated bacteria, SC4TGZ3 and 
SC4TGZ4 were successfully screened for antibacterial against Tuberculosis bacteria. SC4TGZ3 was found to 
inhibit the growth of MDR TB strain HE, MDR TB strain SR and H37Rv. Whereas, SC4TGZ4 was found to 
inhibit the growth of MDR TB strain HE. Based on PCR amplification 16S rDNA softcoral bacateria were 
identified as follows: SC4TGZ3 was closely related to Pseudovibrio sp. and SC4TGZ4 was closely related to 
Alpha proteobacterium sp. 
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Tuberculosis (TB) is one of the major health 
problems in Indonesia.  It is estimated that total 
cases are 528,000 and 86,000 cases deaths. The 
three major indicators of impact: incidence, 
prevalence and mortality rates per 100.000 
population by further monitoring, MDG target 
6.c is  to halve prevalence and death rates by 
2015 compared with 1990 (WHO, 2009).  
 Over the past 20 years , it has been seen 
the worldwide appearance of multidrug-
resistant (MDR) TB. MDR TB is caused by 
Mycobacterium tuberculosis that is resistant at 
least to Isoniazid and Rifampicin, the most 
effective anti-TB drugs and are considered first-
line drugs to be used to treat all persons with 
TB disease ( Gandhi et al., 2010).  The MDR 
TB estimated cases in Indonesia are 10,000 
(WHO, 2009). MDR-TB results from either 
primary infection with resistant bacteria or may 
develop in the course of a patient’s treatment 
(WHO, 2010).   
Resistance to anti-TB drugs occurrs when 
these drugs are misused or mismanaged. 
Examples include when patients do not 
complete their full course of treatment; when 
health-care providers prescribe the wrong 
treatment, the wrong dose, or length of time for 
taking the drugs; when the supply of drugs is 
not always available; or when the drugs are of 
poor quality (Center for Diseases Control, 
2008). Treatment failures also increase the 
numbers of infected people moving into the 
community and thus expose the general 
population to the risk of contracting a resistant 
strain of infection. It is an opportunity to find 
alternative antibiotic to combat the resistant 
bacteria. 
Nature has continuously provided 
mankind with a broad and structurally diverse 
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arsenal of pharmacologically active compounds 
that continue to be utilised as highly effective 
drugs to combat a multitude of deadly diseases 
or as lead structures for the development of 
novel synthetically derived drugs that mirror 
their models from nature. The oceans are the 
source of a large group of structurally unique 
natural products that are mainly accumulated in 
invertebrates such as sponges, tunicates, 
bryozoans, and mollusks (Proksch et al., 2002).  
The development of marine organisms-
derived compounds into drugs has been 
hampered by supply limitations. Symbioses 
between microorganisms and marine organisms 
are abundant and widespread in the sea. Most 
marine invertebrates and algae harbor diverse 
microbial symbionts including prokaryotic 
bacteria, archaea, cyanobacteria, and fungi. 
Increasing evidence implicates microbial 
symbionts as the true source of many marine 
organism-derived compounds, which makes 
marine microbial symbionts a hotspot in the 
field of marine microbiology and marine natural 
products because of their potential for solving 
the bottleneck problem of marine natural 
product supply (Li, 2009).  
Numerous natural products from marine 
invertebrates show striking structural 
similarities to known metabolites of microbial 
origin, suggesting that microorganisms 
(bacteria, microalgae) are at least involved in 
their biosynthesis or are in fact the true sources 
of these respective metabolites. This 
assumption is corroborated by several studies 
on natural products from sponges that proved 
these compounds to be localized in symbiotic 
bacteria or cyanobacteria (Proksch et al., 2002). 
This article describes the characterization 
of soft coral Sinularia sp.-associated bacteria 
that having antibacterial activity against 
tuberculosis bacteria (H37Rv, MDR TB strain 
HE, MDR TB strain SR). The characterization 
is supported by moleculer techniques using 16S 
rDNA approach. 
 
MATERIAL AND METHODS 
 
Sampling Sinularia sp. and isolation 
bacterial symbionts 
 
Collonies of softcoral Sinularia sp. were 
collected by scuba diving from Tanjung Gelam 
waters, Karimunjawa islands, North Java Sea, 
Indonesia. Upon collection, softcorals were put 
into steril plastic bags (Whirl-Pak, Nasco 
USA). The tissue were then rinsed with sterile 
seawater and homogenized with blender. The 
homogenized tissues were serially diluted, 
spread on half strength ZoBell 2216E marine 
agar medium and incubated at room 
temperature for 2x24 hours.  On the basis of 
morphological features colonies were randomly 
picked and purified by making streak plates 




Antibacterial test of Sinularia sp. associated 
bacteria against tuberculosis bacteria was 
performed by using an overlay method. 
Tuberculosis bacteria (H37Rv, MDR TB strain 
HE, MDR TB strain SR) used in this study 
were obtained from Health Laboratory of 
Central Java Province-Semarang. Culture of 
each bacterium in the logarithmic phase was 
mixed with Middle brook 7H9+OADC soft 
agar medium (1% v/v), which were poured on 
to the respective agar surface previously 
inoculated with Sinularia sp. associated 
bacteria that had incubated for 4 days at room 
temperature. Then the plates were incubated at 
room temperature 2x24 hours. Antibacterial 
activity was defined by the formation of 
inhibition zones around the tuberculosis 
bacterial colonies. 
 
PCR amplification and DNA sequencing 
 
PCR amplification was carried out according to 
the method of Radjasa at.al., (2007a). Universal 
primers described by Weisburg et al., (1991) 
was used for PCR amplification. Genomic 
DNA of strains for PCR analysis were obtained 
from cell materials taken from an agar plate, 
suspended in sterile water (Sigma, Germany) 
and subjected to five cycles of freeze (-80oC) 
and thaw (95 oC).  PCR amplification or partial 
16S rRNA gene of Sinularia sp. associated 
bacteria and subsequent sequencing analysis 
were performed according to method of Radjasa 
et al., (2007b).  The determined DNA 
sequences of strains were compared for 
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There were 109 isolates of marine bacteria 
associated with softcoral Sinularia sp, and 2 
 
isolates associated bacteria were found to 
inhibit the growth of tuberculosis bacteria 
(H37Rv, MDRTB strain HE, MDR TB strain 
SR) as shown in Table 1. 
 
Table 1. The growth inhibition zone of Tuberculosis Bacteria 
 
Moleculer identification of active isolates 
of marine bacteria associated with softcoral 
Sinularia sp. based on 16S rDNA, revealed that 
active strains:  SC4TGZ3 was closely related to 
Pseudovibrio sp. and SC4TGZ4 was closely 
related to Alpha proteobacterium sp. (Table 2).  
 
Table 2. Moleculer identification of active isolates obtained from soft coral Sinularia sp. 
 
No Kode Bakteri Length Closest Relative Homology Accession 
 
1. SC4TGZA 458 Alpha 
proteobacterium 
81% DQ097264.1 
2. SC4TGZ3 493 Pseudovibrio sp. 99 % FJ952802.1 
 
The result of BLAST search for SC4TGZ3  and SC4TGZ4  are shown in the following               













Fig. 1 BLAST for  SC4TGZ3 bacteria 
NO Stram Soft Coral H37Rv MDR TB  strain HE 
MDR TB 
 strain SR. 
1. SC4 TGZ3 Sinularia sp. 8.5±0.5 4.533 ± 0.057  6.133±2.307 
2. SC4 TGZ4 Sinularia sp. - 4.95±0.260  6.900 ± 3.61 
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           Fig. 2. BLAST for  SC4TGZ4 bacteria
Discussion 
MDR tuberculosis has become increasingly 
prevalent. Treatment regimens for MDR 
tuberculosis are longer, less effective, less 
tolerable, and more expensive than is 
standardised short-course chemotherapy, and 
include the use of injectable drugs. The 
percentage of patients with MDR tuberculosis 
who are cured is estimated to be no more than 
69% on the basis of results from retrospective 
cohort studies, even when treated for more than 
18 months with directly observed treatment(Ma 
et al., 2010). This is an opportunity to 
investigate new drugs for tuberculosis.  
The causative agent of Tuberculosis is 
Mycobacterium tuberculosis. The member of 
the genus Mycobacterium are non-motile and 
non-sporulated rods, they have high lipid 
content in the wall, probably the highest among 
all bacteria. Lipids constitute more than half of 
the dry weight of the mycobacteria. However, 
the lipid composition of the tubercle bacillus 
may vary during the life cycle in culture, 
depending on the availability of nutrients. The 
waxy coat confers the idiosyncratic 
characteristics of the genus: acid fastness, 
extreme hydrophobicity resistance to injury, 
including that of many antibiotics, and 
distinctive immunological properties. It 
probably also contributes to the slow growth 
rate of some species by restricting the uptake of 
nutrients (Barrera, 2007).  
This research used sensitive strain from 
tuberculosis bacteria Mycobacterium 
tuberculosis H37Rv and the resistant strains: 
MDR TB strain HE (Mycobacterium 
tuberculosis resistant Isoniazid and Etambutol)  
and MDR TB strain SR (Mycobacterium 
tuberculosis resistant Streptomycin and 
Rifampicin).  Isoniazid, Rifampicin, Etambutol 
and Streptomycin are the first line drugs for 
tuberculosis. The Sinularia sp. associated 
bacteria SC4TGZ3 (homolog 99% with 
Pseudovibrio sp.) and SC4TGZ4 (homolog 
81% with Alpha proteobacterium) had potential 
with antibacterial activities.  
Pseudovibrio sp. and 
Alphaproteobacterium have the same class in 
Alphaproteobacteria (α-proteobacteria). They 
are gram negative with an outer membrane 
mainly composed of lipopolysaccharides. These 
bacteria also symbionts of plants and animals 
The α-proteobacteria form one of the largest 
groups within bacteria that includes numerous 
phototrophs, chemolithotrophs, 
chemoorganotrophs and aerobic 
photoheterotrophs. They are abundant 
constituents of various terrestrial and marine 
environments. The intimate association that 
many α-proteobacteria exhibit with the 
eukaryotic organisms is of central importance 
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 from agricultural and medical perspectives 
(Gupta and Mok, 2007).  
Bacterial symbionts of marine 
invertebrates have been known to produce 
secondary metabolites which are potential for 
medical and pharmalogical fields such as 
symbionts of coral Acropora sp. (Radjasa et al., 
2007a) and sponge Haliclona sp (Radjasa et al., 
(2007b). Futher, Radjasa et al., (2007c) 
reported the antibacterial activity of bacterial 
symbionts of softcoral Sinularia polydactyla 
against pathogen Streptococcus equi subsp. 
zooepidemicus. The present study has 
confirmed the importance of bacterial symbiont, 
in particular those having symbioses with 
softcoral Sinularia sp. as the producer of 




Soft coral Sinularia sp. exhibited secondary 
metabolite producing marine bacteria with 
antibacterial activity that potential against 
tuberculosis bacteria: Mycobacterium 
tuberculosis H37Rv and the resistant strains: 
MDR TB strain HE (Mycobacterium 
tuberculosis resistant Isoniazid and Etambutol)  
and MDR TB strain SR (Mycobacterium 
tuberculosis resistant Streptomycin and 
Rifampicin). Further study, however, is needed 
to isolate and purify the active compounds that 
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